Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
With this issue, I am pleased to have the opportunity to congratulate my partner and co-head of the Norton Rose Fulbright restructuring group, Scott Atkins, on an extremely successful three-year term as president of INSOL International. INSOL is the leading global organization of insolvency professionals.
Scott was instrumental in developing a comprehensive strategic review of INSOL through the landmark INSOL 2030 Strategic Plan and by leading several new future-shaping initiatives to enable INSOL to continue to serve its members in the decade to come.
Scott led the INSOL conferences in London 2022, in Tokyo 2023 and, most recently, in San Diego 2024. These were milestone events for INSOL, including celebrating INSOL’s 40th anniversary and driving membership growth to a record 12,300 members from over 108 countries.
As the co-leader of our Restructuring group, Scott provides a fantastic global perspective to help us advise our clients through these turbulent times. Scott’s clear and strategic leadership will be invaluable as the world realigns around geopolitical and technological disruption.
Good reading,
Howard Seife
Global Co-Head of Restructuring
New York
Publication
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023